comparemela.com

Latest Breaking News On - Qorvo biotechnologies - Page 3 : comparemela.com

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

Minnesota
United-states
Michigan
Georgia
Ann-arbor
American
Larry-heaton
Monitoring-products-inc
Linkedin
Instagram
Zomedica-corp
Twitter

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Ful

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today reported consolidated financial results for the four.

United-states
Michigan
Georgia
Ann-arbor
Minnesota
American
Larry-heaton
Instagram
Twitter
Linkedin
Monitoring-products-inc
Facebook

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter ...

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter .

Minnesota
United-states
Georgia
American
Larry-heaton
Company-global-manufacturing-distribution-centers-in-roswell
News-network
Monitoring-products-inc
Zomedica-corp
Qorvo-biotechnologies
Therapeutic-devices
Zomedica-chief-executive-officer

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

United-states
Ann-arbor
Michigan
Minnesota
Georgia
American
Larry-heaton
Facebook
Linkedin
Monitoring-products-inc
Instagram
Twitter

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

Michigan
United-states
Georgia
Minnesota
Ann-arbor
American
Larry-heaton
Facebook
Company-global-manufacturing-distribution-centers-in-roswell
Twitter
Zomedica-corp
Qorvo-biotechnologies

vimarsana © 2020. All Rights Reserved.